BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33036415)

  • 21. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide DNA methylation profiles of low- and high-grade adenoma reveals potential biomarkers for early detection of colorectal carcinoma.
    Fan J; Li J; Guo S; Tao C; Zhang H; Wang W; Zhang Y; Zhang D; Ding S; Zeng C
    Clin Epigenetics; 2020 Apr; 12(1):56. PubMed ID: 32317010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients.
    Yang X; Xu ZJ; Chen X; Zeng SS; Qian L; Wei J; Peng M; Wang X; Liu WL; Ma HY; Gong ZC; Yan YL
    World J Gastroenterol; 2019 May; 25(17):2099-2109. PubMed ID: 31114136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer.
    Dong Z; Dai L; Zhang Y; Fang C; Shi G; Chen Y; Li J; Wang Q; Fu J; Yu Y; Wang W; Cheng L; Liu Y; Lin Y; Wang Y; Wang Q; Wang H; Zhang H; Zhang Y; Su X; Zhang S; Wang F; Qiu M; Zhou Z; Deng H
    PLoS Genet; 2020 Nov; 16(11):e1009159. PubMed ID: 33175846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
    Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D
    Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic signatures of familial cancer are characteristic of tumor type and family category.
    Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P
    Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel serum nucleosomics biomarkers for the detection of colorectal cancer.
    Holdenrieder S; Dharuman Y; Standop J; Trimpop N; Herzog M; Hettwer K; Simon K; Uhlig S; Micallef J
    Anticancer Res; 2014 May; 34(5):2357-62. PubMed ID: 24778043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update.
    Molnár B; Galamb O; Kalmár A; Barták BK; Nagy ZB; Tóth K; Tulassay Z; Igaz P; Dank M
    Expert Rev Mol Diagn; 2019 Jun; 19(6):477-498. PubMed ID: 31046485
    [No Abstract]   [Full Text] [Related]  

  • 29. LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer.
    Nagai Y; Sunami E; Yamamoto Y; Hata K; Okada S; Murono K; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Kawai K; Nozawa H; Ishihara S; Hoon DS; Watanabe T
    Oncotarget; 2017 Feb; 8(7):11906-11916. PubMed ID: 28060757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of global and intragenic hypomethylation in colorectal adenomas improves patient stratification and colorectal cancer risk prediction.
    Debernardi C; Libera L; Berrino E; Sahnane N; Chiaravalli AM; Laudi C; Berselli M; Sapino A; Sessa F; Venesio T; Furlan D
    Clin Epigenetics; 2021 Aug; 13(1):154. PubMed ID: 34372923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating methylated RUNX3 and SFRP1 genes as a noninvasive panel for early detection of colorectal cancer.
    Pasha HF; Radwan MI; Yehia AM; Toam MM
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1342-1349. PubMed ID: 31524773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide analysis of DNA methylation identifies two CpG sites for the early screening of colorectal cancer.
    Wang X; Wang D; Zhang H; Feng M; Wu X
    Epigenomics; 2020 Jan; 12(1):37-52. PubMed ID: 31762318
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential DNA methylation analysis of
    Su JQ; Lai PY; Hu PH; Hu JM; Chang PK; Chen CY; Wu JJ; Lin YJ; Sun CA; Yang T; Hsu CH; Lin HC; Chou YC
    World J Gastroenterol; 2022 Feb; 28(8):825-839. PubMed ID: 35317099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
    Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
    Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer.
    Oh T; Kim N; Moon Y; Kim MS; Hoehn BD; Park CH; Kim TS; Kim NK; Chung HC; An S
    J Mol Diagn; 2013 Jul; 15(4):498-507. PubMed ID: 23747112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant circulating tumor DNA methylation and exosomal microRNA biomarkers for early detection of colorectal cancer.
    Zhang X; Hou H; Jiang M; Zhang X
    Mol Biol Rep; 2023 Mar; 50(3):2743-2750. PubMed ID: 36583782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review.
    Liang TJ; Wang HX; Zheng YY; Cao YQ; Wu X; Zhou X; Dong SX
    Oncotarget; 2017 Jul; 8(28):46468-46479. PubMed ID: 28515349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
    Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of Blood-Based Colorectal Cancer Screening: How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation?
    Worm Ørntoft MB
    Clin Colorectal Cancer; 2018 Jun; 17(2):e415-e433. PubMed ID: 29678513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
    Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
    Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.